CliffBio
small molecule

LEVETIRACETAM

LEVETIRACETAM

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameLEVETIRACETAM
Active ingredientLEVETIRACETAM
Strength100MG/ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2011
Marketing statusDISCN

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.